首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2440篇
  免费   181篇
  国内免费   11篇
耳鼻咽喉   15篇
儿科学   58篇
妇产科学   20篇
基础医学   325篇
口腔科学   94篇
临床医学   177篇
内科学   710篇
皮肤病学   11篇
神经病学   271篇
特种医学   56篇
外科学   460篇
综合类   9篇
预防医学   63篇
眼科学   20篇
药学   89篇
中国医学   9篇
肿瘤学   245篇
  2023年   14篇
  2022年   14篇
  2021年   58篇
  2020年   37篇
  2019年   55篇
  2018年   72篇
  2017年   62篇
  2016年   69篇
  2015年   68篇
  2014年   78篇
  2013年   137篇
  2012年   199篇
  2011年   189篇
  2010年   102篇
  2009年   88篇
  2008年   162篇
  2007年   176篇
  2006年   149篇
  2005年   154篇
  2004年   134篇
  2003年   136篇
  2002年   126篇
  2001年   27篇
  2000年   31篇
  1999年   34篇
  1998年   20篇
  1997年   18篇
  1996年   12篇
  1995年   12篇
  1994年   19篇
  1993年   15篇
  1992年   17篇
  1991年   16篇
  1990年   14篇
  1989年   13篇
  1988年   4篇
  1987年   9篇
  1986年   15篇
  1985年   12篇
  1984年   11篇
  1983年   5篇
  1982年   7篇
  1980年   6篇
  1979年   7篇
  1977年   3篇
  1975年   2篇
  1972年   3篇
  1970年   3篇
  1969年   4篇
  1968年   3篇
排序方式: 共有2632条查询结果,搜索用时 156 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
Ruxolitinib is effective in myeloproliferative neoplasms (MPN) but can cause reactivation of silent infections. We aimed at evaluating viral load and T-cell responses to human cytomegalovirus (HCMV) and Epstein-Barr virus (EBV) in a cohort of 25 MPN patients treated with ruxolitinib. EBV-DNA and HCMV-DNA were quantified monthly using real-time polimerase chain reaction (PCR) on peripheral blood samples, and T-cell subsets were analyzed by flowcytometry. HCMV and EBV-directed T-cell responses were evaluated using the IFN-γ ELISPOT assay. Most patients had CD4+ and/or CD8+ T-cells below the normal range; these reductions were related to the duration of ruxolitinib treatment. In fact, reduced T-lymphocytes' subsets were found in 93% of patients treated for ≥5 years and in 45% of those treated for <5 years (P = .021). The former also had lower median numbers of CD4+ and CD8+ cells. Subclinical reactivation of EBV and HCMV occurred in 76% and 8% of patients. We observed a trend to an inverse relationship between EBV and CMV-specific CD4+ and CD8+ T-cell responses and viral load, and a trend to an inverse correlation with ruxolitinib dose. Therefore, our data suggest that the ruxolitinib treatment may interfere with immunosurveillance against EBV and HCMV.  相似文献   
9.
AIM: To investigate the role of laparoscopy in diagnosis and treatment of intra abdominal infections.METHODS: A systematic review of the literature was performed including studies where intra abdominal infections were treated laparoscopically.RESULTS: Early laparoscopic approaches have become the standard surgical technique for treating acute cholecystitis. The laparoscopic appendectomy has been demonstrated to be superior to open surgery in acute appendicitis. In the event of diverticulitis, laparoscopic resections have proven to be safe and effective procedures for experienced laparoscopic surgeons and may be performed without adversely affecting morbidity and mortality rates. However laparoscopic resection has not been accepted by the medical community as the primary treatment of choice. In high-risk patients, laparoscopic approach may be used for exploration or peritoneal lavage and drainage. The successful laparoscopic repair of perforated peptic ulcers for experienced surgeons, is demonstrated to be safe and effective. Regarding small bowel perforations, comparative studies contrasting open and laparoscopic surgeries have not yet been conducted. Successful laparoscopic resections addressing iatrogenic colonic perforation have been reported despite a lack of literature-based evidence supporting such procedures. In post-operative infections, laparoscopic approaches may be useful in preventing diagnostic delay and controlling the source.CONCLUSION: Laparoscopy has a good diagnostic accuracy and enables to better identify the causative pathology; laparoscopy may be recommended for the treatment of many intra-abdominal infections.  相似文献   
10.
Kuusk  Teele  Biancari  Fausto  Lane  Brian  Tobert  Conrad  Campbell  Steven  Rimon  Uri  D’Andrea  Vito  Mehik  Aare  Vaarala  Markku H. 《BMC urology》2015,15(1):1-4
Epididymal anomalies and patent processus vaginalis are frequently found in boys with cryptorchidism or hydrocele. We conducted this study to evaluate the association between epididymal anomalies and testicular location or patent processus vaginalis in boys with undescended testis or hydrocele. Children undergoing surgery with undescended testis (group A, 136 boys and 162 testes) or communicating hydrocele (group B, 93 boys and 96 testes) were included. Testicular locations and epididymal anomalies were investigated prospectively. An anomalous epididymis was defined as anomalies of epididymal fusion that consisted of loss of continuity between the testis, the epididymis, and the long looping epididymis. The epididymis was considered normal when a normal, firm attachment between the testis, the caput, and the cauda epididymis was present. The mean ages of groups A and B were 24.6 ± 19.7 (range, 8–52 months) and 31.4 ± 20.6 months (range, 10–59 months). The incidence of epididymal anomalies was significantly higher in group A than that in group B (65.4 % vs. 13.5 %, P < 0.001). The incidence of epididymal anomalies in boys with undescended testis was significantly different according to testis location. Epididymal anomalies were observed in 100 %, 91.4 %, and 39.3 % of cases when the testis was located in the abdomen, inguinal canal, and distal to the external inguinal ring, respectively (P < 0.001). We conclude that epididymal anomalies were more frequent in boys with undescended testis than in boys with hydrocele, and that these anomalies were more frequent when undescended testis was at a higher level. These results suggest that testicular location is associated with epididymal anomalies rather than patent processus vaginalis.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号